Yahoo Web Search

Search results

1. • 

     Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU

     Zacks via Yahoo Finance· 5 months ago

     Biogen (BIIB) gets positive CHMP opinion recommending marketing authorization to Skyclarys in the EU...

2. • 

     Biogen's (BIIB) ALS Drug Tofersen Filing Accepted in Europe

     Zacks via Yahoo Finance· 1 year ago

     Biogen BIIB announced that the European Medicines Agency (EMA) has accepted the marketing...

3. • 

     Biogen's (BIIB) FDA Filing for ALS Drug Gets 3 Months Extension

     Zacks via Yahoo Finance· 2 years ago

     The FDA extends the review period for Biogen's (BIIB) NDA for tofersen in SOD1-ALS. This extension...

4. • 

     Biogen's (BIIB) Lecanemab Shows Benefit but With Side Effects

     Zacks via Yahoo Finance· 1 year ago

     Detailed data from Biogen (BIIB) and Eisai's Clarity AD shows that treatment with lecanemab in the...

5. • 

     Biogen's (NASDAQ:BIIB) underlying earnings growth outpaced the favorable return generated for...

     Simply Wall St. via Yahoo Finance· 11 months ago

     The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right...

6. • 

     Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.

     Motley Fool· 9 months ago

     Biogen's (NASDAQ: BIIB) biggest problem in recent times has been growth. The biotech giant's...

7. • 

     Biogen's (NASDAQ:BIIB) investors will be pleased with their favorable 64% return over the last year

     Simply Wall St. via Yahoo Finance· 1 year ago

     Passive investing in index funds can generate returns that roughly match the overall market. But you...

8. • 

     Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake

     Zacks via Yahoo Finance· 3 weeks ago

     Biogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...

9. • 

     What's in Store for Biogen (BIIB) This Earnings Season?

     Zacks via Yahoo Finance· 4 weeks ago

     Biogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its...

10. • 

      Is Biogen Inc.'s (NASDAQ:BIIB) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

      Simply Wall St. via Yahoo Finance· 1 year ago

      Biogen's (NASDAQ:BIIB) stock is up by a considerable 12% over the past month. As most would know,...